NCT00293319View on ClinicalTrials.gov

131 I-MIBG in Treating Patients With Refractory or Relapsed Neuroblastoma

PHASE2CompletedINTERVENTIONAL
Enrollment

164

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

March 31, 2006

Study Completion Date

March 31, 2006

Conditions
Neuroblastoma
Interventions
BIOLOGICAL

filgrastim

RADIATION

iobenguane I 131

Trial Locations (3)

19104

Children's Hospital of Philadelphia, Philadelphia

94115

UCSF Comprehensive Cancer Center, San Francisco

48109-0942

University of Michigan Comprehensive Cancer Center, Ann Arbor

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of California, San Francisco

OTHER

NCT00293319 - 131 I-MIBG in Treating Patients With Refractory or Relapsed Neuroblastoma | Biotech Hunter | Biotech Hunter